Feb 27 (Reuters) - Atara Biotherapeutics Inc:
* ATARA BIOTHERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND RECENT CLINICAL, OPERATIONAL AND STRATEGIC PROGRESS
* QTRLY LOSS PER SHARE $1.36
* Q4 EARNINGS PER SHARE VIEW $-1.34 -- REFINITIV IBES DATA Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.